News
UABDIVULGA
Gene therapy strategies for multiple sclerosis
Researchers of the UAB and VHIR are developing a gene therapy capable of reducing the inflammatory response developed in multiple sclerosis. The results obtained in animal models are encouraging, but further research is needed to optimize the treatment.